top of page
Subtle%20Shapes%20Transparent_edited.png

INSIGHTS

  • Writer's pictureTeam Archbow

The Key to Pharmaceutical Commercial Success


When it comes to successfully launching patient access strategies for a new biosimilar, how much does the size of the pharmaceutical organization matter?
The Key to Pharmaceutical Commercial Success

The Key to Pharmaceutical Commercial Success


In the ever-evolving landscape of the pharmaceutical industry, commercial success is contingent upon far more than just innovative drug development. Superior strategic planning is pivotal in steering pharmaceutical companies toward profitability, market leadership, and fulfilling their mission to improve patient lives. Successfully launching or re-launching a new pharmaceutical into today’s highly competitive market may look simple for those on the outside looking in. But, for those of us in the know, it’s truly anything but.


The market access teams we work with are typically tasked with essential commercial decisions:

  • How will we convince HCPs to prescribe our product?

  • How can we ensure the product reaches the patient when and where they need it?

  • How will we persuade insurers to cover the product?

There are thousands of variations of how those questions can be answered. Still, each should be driven by unique patient, prescriber, and payer needs and carefully considered through the lenses of company objectives, budgets, and timelines.


As a pharmaceutical consulting company, Archbow helps biopharma manufacturers address commercial planning needs with a rigorous approach that includes a customized mix of strategies, such as:

  • Pharmaceutical business analysis, planning, and ideation

  • Pharmaceutical market positioning

  • Biopharma market landscape assessments, including industry trends, competitive intelligence, analog research, real-world benchmarking, and market research

  • Pharmaceutical Fair Market Value

  • Financial and cost modeling

  • PBM contract negotiation

  • LOE market share loss prevention

  • Copay Maximizer and Accumulator mitigation

  • Due diligence and asset evaluation

  • Global pharmaceutical pre-commercial and commercial supply chain strategy & implementation

Superior strategic planning is the cornerstone of pharmaceutical commercial success. By integrating patient-centricity, market insights, regulatory acumen, and adaptability, pharmaceutical companies can navigate the industry's complexities and achieve their goals. In a dynamic landscape, the ability to embrace innovation, foster partnerships, and stay ahead of market trends is paramount. With the proper strategic planning, pharmaceutical companies can not only bring life-saving medications to patients but also thrive in a highly competitive market. That’s where the right advisors, with decades of commercial planning experience, can make a genuine difference.


Learn more about our commercial planning team, and contact us today for assistance with your strategic commercialization needs.


You can also assess our Reimbursement Blueprint Webinar and understand the four essential steps to create a HUB that customers will appreciate and use.


Related Blog Posts:

 

Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, can leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and client’s success, and connect with us via email, LinkedIn, Twitter, or subscribe to this blog which you can do below.


Comments


bottom of page